a quantitative enzyme-linked immunosorbent assay was used to measure the concentration of fluid-phase complement c5b-9 complexes ( sc5b-9 ) in the cerebrospinal fluid ( csf ) of 14 patients with acute monophasic guillain-barre syndrome ( gbs ) , 21 patients with multiple sclerosis ( ms ) , and 11 patients with noninflammatory central nervous system ( cns ) diseases .
C0026769
multiple sclerosis
C0007682
central nervous system